Normality and homoscadacity were tested for prior to analysis using box-plot visualisation and Levene's test respectively.
These two screens relied on the use of reporters comprising a signal sequence fused to HRP and luciferase, respectively, without direct visualisation of the secretory pathway, at least in the primary screens.
To analyse morphological alterations, two different approaches were used in this work: (i) labelling of lipid droplets and DNA with specific fluorescent dyes (Nile red and DAPI, respectively); and (ii) visualisation of general ultrastructural alterations by transmission electron microscopy.
a, b Axial ultrasound and MRI at 33 and 35 weeks' gestation respectively demonstrates non-visualisation of the CSP, parallel orientation of lateral ventricles (arrows), and colpocephaly (dotted arrow).
This antibody was labelled with either the dye AF 680 (AF 680 8/9-mAb) or a chelating ligand containing zirconium-89 (Zr-8/9-mAb) for visualisation with fluorescence imaging and PET, respectively.
Tumour sections from DMXAA-treated mice showed 12.5- and 12-fold increases in apoptosis staining over that in tumour sections from untreated mice using alkaline phosphatase, or POD/DAB, respectively, as the enzyme system for visualisation of apoptosis staining.
Given that early detection of a neoplasm is worthwhile for either a bleeding phenotype or a phenotype that enables visualisation (as detected by FOBT and flexible sigmoidoscopy, respectively), detection of a neoplasm based on other factors such as molecular characteristics may have the same benefit, but this is yet to be established.
Images were captured after an exposure period of 30 s for each LED/filter set using the G-Box EF2 Gel Documentation System (Syngene Europe, Cambridge, UK): Blue-LED/Filt525 and Green-LED/Filt605 for the visualisation of 6-FAM and ATTO565 labelled PCR products, respectively.
Proteins were resolved by 10% (c-Src) and 6% (phospho 416 Src) SDS PAGE gels respectively, and transferred to nitrocellulose membranes prior to visualisation using anti-v-Src mAb (Ab-1) (0.1 μg ml−1, Oncogene Research Products, Cambridge, MA, USA).
No significant differences occurred according to the SCJ visualisation (31.8% and 27.8% for visible and not visible SCJ, respectively, P=0.63).
